|
시장보고서
상품코드
1977922
의약품 품질 관리 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)Global Pharmaceutical Quality Control Market Size, Share, Trends & Growth Analysis Report 2026-2034 |
||||||
의약품 품질 관리 시장 규모는 2025년 66억 달러에서 2034년에는 188억 6,000만 달러에 달할 것으로 예측되며, 2026년부터 2034년까지 CAGR 12.38%로 성장할 전망입니다.
세계 의약품 품질 관리 시장은 엄격한 규제 요건과 의약품 개발 활동의 증가로 인해 꾸준히 성장하고 있습니다. 품질 관리 프로세스는 안전성, 유효성 및 국제 표준에 대한 적합성을 보장합니다. 제네릭 의약품과 바이오의약품의 생산이 증가함에 따라 제약사들은 첨단 분석 테스트 솔루션에 많은 투자를 하고 있습니다. GMP(Good Manufacturing Practice)에 대한 중요성이 높아지면서 품질 관리 시스템에 대한 수요가 더욱 증가하고 있습니다.
주요 성장 요인으로는 크로마토그래피, 분광분석, 분자검사 기술 등 분석 기기의 발전이 꼽힙니다. 바이오의약품과 바이오시밀러가 복잡해짐에 따라 정밀한 시험 및 검증 프로세스가 요구되고 있습니다. 또한, 품질시험의 위탁연구기관(CRO)에 대한 아웃소싱 증가도 시장 성장에 기여하고 있습니다. 세계 각국의 규제 당국이 보다 엄격한 컴플라이언스 기준을 시행함에 따라 테스트 인프라에 대한 투자도 증가하고 있습니다.
의약품 혁신이 전 세계적으로 계속 확대되고 있는 가운데, 향후 전망은 여전히 강세를 보이고 있습니다. 맞춤형 의료와 첨단 치료의 성장을 위해서는 보다 높은 수준의 품질 관리 기술이 요구됩니다. 신흥 시장에서는 규제 프레임워크가 강화되면서 수요를 더욱 촉진하고 있습니다. 자동화와 디지털 데이터 관리 시스템은 업무 효율성 향상에 기여할 것으로 기대되며, 의약품 품질 관리 시장을 지속가능한 발전으로 이끌 것입니다.
목차
제1장 소개
제2장 주요 요약
제3장 시장 변수, 동향, 프레임워크
제4장 세계의 의약품 품질 관리 시장 : 제품별
제5장 세계의 의약품 품질 관리 시장 : 분석 유형별
제6장 세계의 의약품 품질 관리 시장 : 제품 시험별
제7장 세계의 의약품 품질 관리 시장 : 지역별
제8장 경쟁 구도
제9장 기업 개요
KSM 26.04.07The Pharmaceutical Quality Control Market size is expected to reach USD 18.86 Billion in 2034 from USD 6.60 Billion (2025) growing at a CAGR of 12.38% during 2026-2034.
The Global Pharmaceutical Quality Control Market is expanding steadily due to stringent regulatory requirements and increasing drug development activities. Quality control processes ensure safety, efficacy, and compliance with global standards. With rising production of generic drugs and biologics, pharmaceutical companies are investing heavily in advanced analytical testing solutions. Growing emphasis on Good Manufacturing Practices (GMP) further drives demand for quality control systems.
Major growth drivers include advancements in analytical instruments such as chromatography, spectroscopy, and molecular testing technologies. The rising complexity of biologics and biosimilars requires precise testing and validation processes. Additionally, increasing outsourcing of quality testing to contract research organizations is contributing to market growth. Regulatory authorities worldwide are enforcing stricter compliance norms, boosting investment in testing infrastructure.
Future prospects remain strong as pharmaceutical innovation continues to expand globally. The growth of personalized medicine and advanced therapies will require more sophisticated quality control techniques. Emerging markets are strengthening regulatory frameworks, further driving demand. Automation and digital data management systems are expected to enhance operational efficiency, positioning the pharmaceutical quality control market for sustained development.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
MARKET SEGMENTATION
By Product
- Consumables
- Instruments
- Services
By Analysis Type
- Sterility Testing
- Bioburden Testing
- Endotoxin Testing
- Stability Testing
- Extractable & Leachable Testing
- Raw Material Testing
- Others
By Products Tested
- Vaccines
- Plasma Products
- Drugs
COMPANIES PROFILED
- BioMerieux SA, SGS SA, Charles River Laboratories International Inc, WiXi AppTec, Merck KGaA, Thermo Fisher Scientific Inc, Toxikon Corporation, Sartorius AG, REMI Group, Perkin Elmer
- We can customise the report as per your requirements.
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL PHARMACEUTICAL QUALITY CONTROL MARKET: BY PRODUCT 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Product
- 4.2. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL PHARMACEUTICAL QUALITY CONTROL MARKET: BY ANALYSIS TYPE 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Analysis Type
- 5.2. Sterility Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. Bioburden Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.4. Endotoxin Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.5. Stability Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.6. Extractable & Leachable Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.7. Raw Material Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL PHARMACEUTICAL QUALITY CONTROL MARKET: BY PRODUCTS TESTED 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast Products Tested
- 6.2. Vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Plasma Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.4. Drugs Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL PHARMACEUTICAL QUALITY CONTROL MARKET: BY REGION 2022-2034(USD MN)
- 7.1. Regional Outlook
- 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.2.1 By Product
- 7.2.2 By Analysis Type
- 7.2.3 By Products Tested
- 7.2.4 United States
- 7.2.5 Canada
- 7.2.6 Mexico
- 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.3.1 By Product
- 7.3.2 By Analysis Type
- 7.3.3 By Products Tested
- 7.3.4 United Kingdom
- 7.3.5 France
- 7.3.6 Germany
- 7.3.7 Italy
- 7.3.8 Russia
- 7.3.9 Rest Of Europe
- 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.4.1 By Product
- 7.4.2 By Analysis Type
- 7.4.3 By Products Tested
- 7.4.4 India
- 7.4.5 Japan
- 7.4.6 South Korea
- 7.4.7 Australia
- 7.4.8 South East Asia
- 7.4.9 Rest Of Asia Pacific
- 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.5.1 By Product
- 7.5.2 By Analysis Type
- 7.5.3 By Products Tested
- 7.5.4 Brazil
- 7.5.5 Argentina
- 7.5.6 Peru
- 7.5.7 Chile
- 7.5.8 South East Asia
- 7.5.9 Rest of Latin America
- 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.6.1 By Product
- 7.6.2 By Analysis Type
- 7.6.3 By Products Tested
- 7.6.4 Saudi Arabia
- 7.6.5 UAE
- 7.6.6 Israel
- 7.6.7 South Africa
- 7.6.8 Rest of the Middle East And Africa
Chapter 8. COMPETITIVE LANDSCAPE
- 8.1. Recent Developments
- 8.2. Company Categorization
- 8.3. Supply Chain & Channel Partners (based on availability)
- 8.4. Market Share & Positioning Analysis (based on availability)
- 8.5. Vendor Landscape (based on availability)
- 8.6. Strategy Mapping
Chapter 9. COMPANY PROFILES OF GLOBAL PHARMACEUTICAL QUALITY CONTROL INDUSTRY
- 9.1. Top Companies Market Share Analysis
- 9.2. Company Profiles
- 9.2.1 BioMerieux SA
- 9.2.2 SGS S.A
- 9.2.3 Charles River Laboratories International Inc
- 9.2.4 WiXi AppTec
- 9.2.5 Merck KGaA
- 9.2.6 Thermo Fisher Scientific Inc
- 9.2.7 Toxikon Corporation
- 9.2.8 Sartorius AG
- 9.2.9 REMI Group
- 9.2.10 Perkin Elmer
